1. Osteoblastic cell response to Al₂O₃-Ti composites as bone implant materials

Marjan Bahraminasab* , Samaneh Arab, Somaye Ghaffari

BioImpacts. 2022;12(3): 247-259. doi: 10.34172/bi.2021.2330

PMCID: PMC9124877 PMID: 35677667 Scopus ID: 85132130879

Article

PDF

Full Text

XML

Cited By:

Our in-vitro findings demonstrated that the 75Ti, 50Ti, and 25Ti composites havehigh potential to be used as load-bearing orthopedic materials.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons

1. Osteoblastic cell response to Al2O3-Ti composites as bone implant materials

1. Osteoblastic cell response to Al₂O₃-Ti composites as bone implant materials